On Nov 01, major Wall Street analysts update their ratings for $Option Care Health (OPCH.US)$, with price targets ranging from $26 to $34.
Deutsche Bank analyst Pito Chickering maintains with a buy rating, and adjusts the target price from $36 to $30.
Jefferies analyst Brian Tanquilut downgrades to a hold rating, and adjusts the target price from $38 to $26.
Truist Financial analyst David S Macdonald maintains with a buy rating, and sets the target price at $34.
Barrington analyst Michael Petusky maintains with a buy rating, and adjusts the target price from $40 to $32.
Furthermore, according to the comprehensive report, the opinions of $Option Care Health (OPCH.US)$'s main analysts recently are as follows:
The outlook for Option Care Health suggests that the uncertainty surrounding the pricing dynamics for Stelara is likely to continue in the coming months, which could keep the stock's performance constrained. With anticipated margin compression for Stelara, there is a projection of a 5% reduction in 2025 EBITDA estimates, leading to less clarity regarding Option Care's fundamental growth trajectory.
Here are the latest investment ratings and price targets for $Option Care Health (OPCH.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
